Salahop, Judie C.

HRN: 16-69-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2026
03/09/2026
IV
500mg
Q8
Stab Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: